Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma
Clinical trial NCT04150562 · TERMINATED
Trial details
- NCT number
- NCT04150562
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2021-07-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.